Low Back Pain study: Erector Spinae Plane Block
Official title Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
ClinicalTrials.gov ID: NCT06745453
What this study is testing
- What it's testing
- The study wants to find out if the nerve block reduces pain right after treatment and improves pain, disability, and ability to work after one week.
- Who it's for
- Adults who come to the emergency department with low back pain.
- What's involved
- You will receive either the nerve block or a harmless placebo injection, then report your pain for up to two hours and again at 7 days.
- Time commitment
- The visit lasts a few hours in the emergency department, with a follow‑up report at 7 days.
You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (age ≥18 years) presenting to the emergency department with isolated low back pain present less than 6 total weeks.
You likely can't join if
- Do not speak English or Spanish as a primary language
- Are incarcerated
- Have a known pregnancy
- Are allergic to amide-type local anesthetics
- Are unable to tolerate positioning for the procedure
- Have a critical illness precluding the ability to perform the procedure.
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.